Description: Taj Pharma, the well-known Colistimethate Sodium for Injection IP 3MIU manufacturer in India gives the assurance of high-quality and purity. Colistimethate Sodium for Injection IP is an antibiotic that fights bacteria. It is used to treat severe bacterial infections of the body. It is commonly used for critically ill patients admitted to the hospital. Colistimethate Sodium for Injection IP Suppliers ✓ Finished Colistimethate Sodium for Injection IP 3MIU Manufacturers in India – Africa ✓ Middle East ✓ LTAM ✓premium Suppliers & Exporter for Colistimethate Sodium for Injection IP 3MIU. Taj Pharma is a trusted manufacturer and exporter of Colistimethate Sodium for Injection IP 3MIU from Vapi, Gujarat, India. This powerful antibiotic is widely used in hospitals to treat severe bacterial infections caused by multidrug-resistant organisms such as Pseudomonas aeruginosa and Klebsiella pneumoniae. Known for its high purity and global-standard manufacturing, Taj Pharma ensures each batch is produced in WHO-GMP certified facilities, making it suitable for both domestic and international markets, including Africa, the Middle East, and LATAM. Colistimethate Sodium for Injection IP 3MIU is administered under medical supervision, with dosage determined by the severity of infection and renal function. Taj Pharma’s product is known for its reliability, affordability, and compliance with international pharmacopoeia standards. While generally well-tolerated, it may cause side effects like dizziness, gastrointestinal discomfort, and renal toxicity in some patients. The drug is not recommended during pregnancy unless absolutely necessary but is considered safe during breastfeeding. Taj Pharma also offers PCD Pharma franchise opportunities and ensures fast PAN India supply. With unmatched quality assurance and export capabilities, Taj Pharma stands as a leading supplier of Colistimethate Sodium Injection 3MIU in India and beyond. Taj Pharma India is Top known Manufacturer, Exporter and Supplier of Colistimethate Sodium for Injection IP 3MIU from Vapi, Gujarat India. Colistimethate Sodium for Injection IP may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Dimensions: 2560 x 1707
File Type: jpeg
File Size: 192 KB
